16 December 2020 - Deborah Wilkes
Premium
New Zealand’s Medicines Classification Committee (MCC) is sticking by its recommendation that pholcodine should be reverse-switched from pharmacy-only to pharmacist-only status. The MCC has also made recommendations on fexofenadine, flurbiprofen and ibuprofen.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.